Moderna (MRNA) Capital Expenditures Growth (1y) (2019 - 2026)
Moderna (MRNA) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moderna | 21.94 Bn | 16.73 Bn | -566.00 Mn | -70.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.09% |
| Dec 31, 2025 | 105.26% |
| Sep 30, 2025 | 135.33% |
| Jun 30, 2025 | -138.46% |
| Mar 31, 2025 | -40.31% |
| Dec 31, 2024 | -96.60% |
| Sep 30, 2024 | -797.67% |
| Jun 30, 2024 | 2,375.00% |
| Mar 31, 2024 | 73.45% |
| Dec 31, 2023 | 507.61% |
| Sep 30, 2023 | -51.69% |
| Jun 30, 2023 | -105.16% |
| Mar 31, 2023 | 76.56% |
| Dec 31, 2022 | 104.44% |
| Sep 30, 2022 | 8,800.00% |
| Jun 30, 2022 | 252.27% |
| Mar 31, 2022 | 204.76% |
| Dec 31, 2021 | -18.18% |
| Sep 30, 2021 | -75.00% |
| Jun 30, 2021 | 2,100.00% |